- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT06218238
Ossur Power -polven biomekaaninen arviointi henkilöillä, joilla on transfemoraalinen amputaatio (OPKTFA)
Parantavatko transfemoraaliset proteesit polviproteesin taivutuksella ja pidennyksellä liikkuvuutta? Ossur Power Kneen biomekaaninen arviointi
Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The Ossur Power Knee is the only commercially-available MPK that uses a motor to provide active power generation during walking and other activities. The purpose of this proposed investigation is to perform and compare biomechanical evaluations of the Power Knee and Ossur Rheo XC, a passive MPK, during walking and other activities by prosthesis users. Furthermore, mobility between male and female subjects will be compared to determine if there are differences in prosthetic knee usage on the basis of sex.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
The anatomical knee is a complex, polycentric joint characterized by a large range of motion in the sagittal plane and limited mobility in the coronal and transverse planes. The sagittal plane motion is used for progression in stance phase, and limb clearance and advancement in swing. Limb prostheses are intended to restore function and cosmesis in persons with limb loss. The complexity and function of prosthetic components have advanced significantly as technology has improved, but a state-of-the-art artificial limb is still a relatively poor substitute for an anatomical one. Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the user during gait. The Ossur Power Knee, which was first introduced in 2006, is the only MPK that uses a motor to provide active power generation during walking and other activities involving knee flexion and extension. Last year, Ossur released the 3rd generation of its Power Knee and appears to have addressed many of the previous shortcomings in terms of reduced weight, less noise, lower cost and longer battery life. Therefore, the newest version of the Power Knee warrants a fresh evaluation since it is, in essence, substantially different in design and function from previous models.
The purpose of this proposed investigation is to perform biomechanical evaluations of the new Ossur Power Knee during walking and other activities by transfemoral prosthesis users. Using a cross-over experimental design, approximately 20 unilateral, transfemoral amputee subjects (10 men and 10 women) will be evaluated in the Jesse Brown VAMC Motion Analysis Research Laboratory (MARL) while wearing the Ossur Power Knee and Ossur Rheo XC, which is a passive MPK device. Furthermore, the Ossur Power Knee may offer distinct advantages to female prosthesis users, so mobility will be compared between men and women to determine if differences exist on the basis of sex. The specific aims and hypotheses of this project are:
Aim 1: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on the gait of unilateral, transfemoral prosthesis users during level walking. Kinematic and kinetic data will be collected as subjects walk in the MARL. Hypothesis--the active knee flexion and extension provided by the Ossur Power Knee will (1) improve walking performance, and (2) reduce metabolic energy cost during ambulation.
Aim 2: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on stairs, slopes and during sit-to-stand/stand-to-sit activities of unilateral, transfemoral prosthesis users. Kinematic data will be collected as subjects perform these activities. Hypothesis--subjects will have improved performance when using the Ossur Power Knee.
Aim 3: To analyze and compare gender specific data between subjects using the Ossur Power Knee and the Ossur Rheo XC. Hypothesis--male and female subjects will demonstrate substantially different abilities to use the two knee components, indicating that gender specific components should be further investigated and developed. Research focusing on the unique prosthetic needs of women Veterans is currently a special emphasis area of the VA RR&D Service.
Subjects will also be administered questionnaires and provided at-home diaries to document their perceptions of comfort, exertion and stability while using the different prosthetic knee units.
The repeated-measures, cross-over protocol design enables each subject to serve as their own control, and it will be determined whether statistically significant changes occur in their performance measures. A two-way mixed-methods ANOVA will be used to assess the main and interaction effects of sex (male, female) and knee type (Ossur Power Knee, Rheo XC). As a conservative approach, a Bonferroni correction will be used to account for the family-wise Type I error rate because multiple outcomes will be used to address each hypothesis.
Increased understanding about how the Ossur Power Knee affects the abilities of transfemoral prosthesis users will facilitate appropriate component selection by prosthetists and ultimately improve quality of life for prosthesis users.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Rebecca Stine, MS
- Puhelinnumero: (312) 503-5726
- Sähköposti: rebecca.stine@va.gov
Tutki yhteystietojen varmuuskopiointi
- Nimi: Steven A Gard, PhD
- Puhelinnumero: (312) 503-5718
- Sähköposti: steven.gard@va.gov
Opiskelupaikat
-
-
Illinois
-
Chicago, Illinois, Yhdysvallat, 60612
- Rekrytointi
- Jesse Brown VA Medical Center, Chicago, IL
-
Ottaa yhteyttä:
- Rebecca Stine, MS
- Puhelinnumero: (312) 503-5726
- Sähköposti: rebecca.stine@va.gov
-
Päätutkija:
- Steven A Gard, PhD
-
Ottaa yhteyttä:
- Steven A Gard, PhD
- Puhelinnumero: (312) 503-5718
- Sähköposti: steven.gard@va.gov
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Unilateral, transfemoral amputation (any etiology)
- Residual limb length classified as standard (i.e., medium) to long
- Prosthesis user for at least 1 year prior to enrolling in the study
- K3 or K4 level ambulator
- Good sensation on their residual limb(s) (upon routine clinical examination)
- Good skin integrity upon visual inspection
- Does not require the use of assistive devices to walk for short distances
- Not currently taking medications that are known to affect balance or gait
- Presents with good socket fit based upon a standard assessment by the study prosthetist
Exclusion Criteria:
- Bilateral amputations
- Individuals with a knee disarticulation
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Crossover-tehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Ossur Power Knee
Subjects will be fitted with the Ossur Power Knee, which has powered flexion and extension. |
Subjects will be fitted and trained on the Ossur Power Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.
Muut nimet:
|
|
Active Comparator: Ossur Rheo XC Knee
Subjects will be fitted with the Ossur Rheo XC Knee, which is a conventional microprocessor-controlled prosthetic knee joint that modulates the amount of damping during flexion and extension. |
Subjects will be fitted and trained on the Ossur Rheo XC Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Walking speed
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
|
Metabolic energy cost
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
The metabolic energy rate will be measured as subjects walk at their freely selected speed on a level treadmill, which will be converted to metabolic energy cost (energy expended per unit distance). |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
|
Sit-to-stand/stand-to-sit symmetry
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Knee kinematics and load distribution between the sound and prosthetic sides will be measured as participants stand up and sit down in a chair. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Step length
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
The step lengths of the sound and prosthetic sides will be measured as participants walk on level ground at slow, normal and fast speeds. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
|
Toe clearance during swing phase
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Toe clearance during swing phase on the prosthetic side will be measured as participants walk on level ground at slow, normal and fast speeds. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
|
Sound leg loading rate
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
The sound leg loading rate during walking will be measured as participants walk on level ground at slow, normal and fast speeds. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
|
Kinematics of pelvic motion
Aikaikkuna: To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Pelvic tilt, rotation and obliquity will be measured as participants walk on level ground at slow, normal and fast speeds. |
To be measured after the 1-month accommodation period of wearing each prosthetic knee component
|
Yhteistyökumppanit ja tutkijat
Tutkijat
- Päätutkija: Steven A Gard, PhD, Jesse Brown VA Medical Center, Chicago, IL
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- A4541-R
- RX004541-01A2 (Muu apuraha/rahoitusnumero: VA RRD)
- 5I01RX004541-02 (Yhdysvaltain NIH-apuraha/sopimus)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .